SOLVAY PHARMACEUTICALS GMBH – Trademark Portfolio
Entity Type: 03
SOLVAY PHARMACEUTICALS GMBH holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CREON. The owner is based in HANOVER.
HANS-BOCKLER-ALLEE 20
HANOVER D30173 , DE
Showing of trademarks Trademarks
Trademark Classifications
SOLVAY PHARMACEUTICALS GMBH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does SOLVAY PHARMACEUTICALS GMBH have?
SOLVAY PHARMACEUTICALS GMBH has 16 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 9 cancelled.
What trademark classes does SOLVAY PHARMACEUTICALS GMBH file in?
SOLVAY PHARMACEUTICALS GMBH files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SOLVAY PHARMACEUTICALS GMBH's most well-known trademarks?
SOLVAY PHARMACEUTICALS GMBH's registered trademark portfolio includes well-known marks such as CREON. These are among 1 currently registered trademark in the portfolio.
What is SOLVAY PHARMACEUTICALS GMBH's trademark registration success rate?
SOLVAY PHARMACEUTICALS GMBH has a 7% trademark registration rate, with 1 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.